|
Convatec Group PLC (CTEC)
31 May 2023 Convatec Group Plc Total Voting Rights The following notification is made in accordance with the UK Financial Conduct Authority's Disclosure and Transparency Rule 5.6.1. As at 31 May 2023, the Company's issued capital with voting rights consisted of 2,045,589,597 ordinary shares of 10p each (“Shares”). The Company does not hold any Shares in Treasury at the date of this disclosure. The above figure (2,045,589,597) can be used by shareholders as the denominator for the calculations by which to determine if they are required to notify their interest in, or a change to, their interest in the Company under the UK Financial Conduct Authority's Disclosure and Transparency Rules.
Enquiries
Grace McCalla, Assistant Company Secretary +44(0)7575353388
Convatec Group Plc’s LEI code is 213800LS272L4FIDOH92
About Convatec
Pioneering trusted medical solutions to improve the lives we touch: Convatec is a global medical products and technologies company, focused on solutions for the management of chronic conditions, with leading positions in advanced wound care, ostomy care, continence and critical care, and infusion care. With around 10,000 colleagues, we provide our products and services in almost 100 countries, united by a promise to be forever caring. Our solutions provide a range of benefits, from infection prevention and protection of at-risk skin, to improved patient outcomes and reduced care costs. Group revenues in 2022 were over $2 billion. The company is a constituent of the FTSE 100 Index (LSE: CTEC). To learn more about Convatec, please visit
Dissemination of a Regulatory Announcement, transmitted by EQS Group. The issuer is solely responsible for the content of this announcement. |
| ISIN: | GB00BD3VFW73 |
| Category Code: | TVR |
| TIDM: | CTEC |
| LEI Code: | 213800LS272L4FIDOH92 |
| Sequence No.: | 247622 |
| EQS News ID: | 1645963 |
| End of Announcement | EQS News Service |
|
|
